Sustained phosphorylation of cytosolic phospholipase A2 accompanies cycloheximide- and adenovirus-induced susceptibility to TNF

Journal of Immunology

Volumn 161, Issue 3, 1998, Pages 1525-1532

  O'Brien, Jennifer B ^a   Piddington, Debra L ^a   Voelkel Johnson, Christina ^b   Richards, Debra J ^a   Hadley, Leslie A ^a   Laster, Scott M ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; MITOGEN ACTIVATED PROTEIN KINASE; ORTHOVANADIC ACID; PHOSPHATASE INHIBITOR; PHOSPHOLIPASE A2; PHOSPHOPROTEIN; RECOMBINANT TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; APOPTOSIS; ARACHIDONIC ACID METABOLISM; ARTICLE; CYTOSOL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME PHOSPHORYLATION; ENZYME SPECIFICITY; IMMUNOREGULATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

3T3 CELLS; ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM; CELL LINE; CYCLOHEXIMIDE; CYTOSOL; ENZYME ACTIVATION; FIBROBLASTS; IMMUNITY, NATURAL; IMMUNOPHENOTYPING; MICE; MICE, INBRED C3H; PHOSPHOLIPASES A; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032146856     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Sugarman, B. J., B. B. Aggarwal, P. E. Hass, I. S. Figari, M. A. Palladino, Jr., and H. M. Shepard. 1985. Recombinant human TNF-α: effects on proliferation of normal and transformed cells in vitro. Science 230:943.
2. Fransen, L., J. Van Der Heyden, R. Ruysschaert, and W. Fiers. 1986. Recombinant TNF: its effect and its synergism with IFN-γ on a variety of normal and transformed cell lines. Eur. J. Cancer Clin. Oncol. 22:419.
3. Kull, F. C., and P. Cuatrecasas. 1981. Possible requirement of internalization in the mechanism of in vitro cytotoxicity in tumor necrosis serum. Cancer Res. 41:4885.
4. Ostrove, J. M., and G. E. Gifford. 1979. Stimulation of RNA synthesis in L929 cells by rabbit TNF. Proc. Soc. Exp. Biol. Med. 160:354.
5. Wong, G. H. W., J. H. Elwell, L. W. Oberley, and D. V. Goeddel. 1989. Manganous Superoxide dismutase is essential for cellular resistance to cytotoxicity of TNF. Cell 58:923.
6. Boss, J. M., S. M. Laster, and L. R. Gooding. 1991. Sensitivity to TNF-mediated cytolysis is unrelated to manganous Superoxide dismutase messenger RNA levels among transformed mouse fibroblasts. Immunology 73:309.
7. Kumar, S., and C. Baglioni. 1991. Protection from TNF-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J. Biol. Chem. 266:20960.
8. Pytel, B. A., K. Peppel, and C. Baglioni. 1990. Plasminogen activator inhibitor type-2 is a major protein induced in human fibroblasts and SK-MEL-109 melanoma cells by TNF. J. Cell. Physiol. 144:416.
9. Beg, A. A., and D. Baltimore. 1996. An essential role for NF-KB in preventing TNF-α-induced cell death. Science 274:782.
10. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787.
11. Chen, M. J., B. Holskin, J. Strickler, J. Gorniak, M. A. Clark, P. J. Johnson, M. Mitcho, and D. Shalloway. 1987. Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF. Nature 330:581.
12. Duerksen-Hughes, P., W. S. M. Wold, and L. R. Gooding. 1989. Adenovirus E1A renders infected cells sensitive to cytolysis by TNF. J. Immunol. 143:4193.
13. Su, F., and R. J. Schneider. 1997. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by TNF. Proc. Natl. Acad. Aci USA 94:8744.
14. Lorence, R. M., P. A. Rood, and K. W. Kelley. 1988. Newcastle disease virus as an antineoplastic agent: induction of TNF-α and augmentation of its cytotoxicity. J. Natl. Cancer Inst. 80:1305.
15. Matsuyama, T., Y. Hamamoto, G.-I. Soma, D. Mizuno, N. Yamamoto, and N. Kobyashi. 1989. Cytocidal effect of TNF on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication. J. Virol. 63:2504.
16. Koff, W. C., and A. V. Fann. 1986. Human TNF-α kills herpes virus-infected cells but not normal cells. Lymphokine Res. 5:215.
17. Gooding, L. R., and W. S. M. Wold. 1990. Molecular mechanisms by which adenoviruses counteract antiviral immune defenses. Crit. Rev. Immunoi 10:53.
18. Svensson, C., M. Bindesson, E. Nyberg, S. Under, N. Jones, and G. Akusjarvi. 1991. Independent transformation activity by adenovirus-5 E1A-conserved regions 1 or 2 mutants. Virology 182:553.
19. Arany, Z., W. R. Sellers, D. M. Livingston, and R. Eckner. 1994. E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 77:799.
20. Bandara, L. R., and N. B. La Thangue. 1991. Adenovirus E1A prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature 351:494.
21. Shisler, J., P. Duerksen-Hughes, T. M. Hermiston, W. S. M. Wold, and L. R. Gooding. 1996. Induction of susceptibility to TNF by E1A is dependent of binding to either p300 or p105-Rb and induction of DNA synthesis. J. Virol. 70:68.
22. White, E., P. Sabbatini, M. Debbas, W. S. M. Wold, D. I. Kusher, and L. R. Gooding. 1992. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by TNF-α. Mol Cell. Biol. 12:2570.
23. Gooding, L. R., L. W. Elmore, A. E. Tollefson, H. A. Brady, and W. S. M. Wold. 1988. A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by TNF. Cell 53:341.
24. Gooding, L. R., I. O. Sofola, A. E. Tollefson, P. Duerksen-Hughes, and W. S. M. Wold. 1990. The adenovirus E3-14.7K protein is a general inhibitor of TNF-mediated cytolysis. J. Immunol. 145:3080.
25. Gooding, L. R., T. S. Ranheim, A. E. Tollefson, L. Aquino, P. Duerksen-Hughers, T. M. Horton, and W. S. M. Wold. 1991. The 10,4000- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by TNF. J. Virol. 65:4114.
26. Cook, J. L., D. L. May, B. A. Wilson, B. Holskin, M. Chen, D. Shalloway, and T. A. Walker. 1989. Role of TNF-α in El A oncogene-induced susceptibility of neoplastic cells to lysis by NK cells and activated macrophages. J. Immunol. 142:4527.
27. Walker, T. A., B. A. Wilson, A. M. Lewis, Jr., and J. L. Cook. 1991. E1A oncogene induction of cytolytic susceptibility eliminates sarcoma cell tumorigenicity. Proc. Natl. Acad. Sci. USA 88:6491.
28. 2 is phosphorylated and activated by MAP kinase. Cell 72:269.
29. 2 activation in vivo requires phosphorylation followed by an increased mtracellular calcium concentration. Biochem. J. 313:91.
30. de Carvalho, M. G. S., A. L. McCormack, E. Olson, F. Ghomashchi, M. H. Gelb, J. R. Yates III, and C. C. Leslie. 1996. Identification of phosphorylation sites of human 85-kDa cytosolic phospholipase A2 expressed in insect cells and present in human monocytes. J. Biol. Chem. 271:6987.
31. Fernandez, B., and J. Basinde. 1991. Receptor-mediated activation of arachidonic acid release in mouse peritoneal-macrophage s is linked to extracellular calcium influx. Biochem. Biophys. Res. Commun. 180:1036.
32. 2+-dependent translocation domain with homology to PKC and GAP. Cell 65:1043.
33. 2 to the nuclear envelope and endoplasmic reticulum. J. Biol. Chem. 270:30749.
34. 2 in human melanoma tumor cells. J. Immunol. 156:201.
35. 2 is required for the lysis of adenovirus-infected cells by TNF. J. Virol. 70:8502.
36. 2 is crucial in the cytotoxic action of TNF. J. Biol. Chem. 268:11290.
37. 2 is necessary for TNF α-induced ceramide generation in L929 cells. J. Biol. Chem. 272:17196.
38. 2 in TNF-induced apoptosis. Proc. Natl Acad. Sci. USA 94:5073.
39. Jones, N., and T. Shenk. 1979. Isolation of adenovirus type 5 host range deletion mutants defective for transformation in rat embryo cells. Cell 17:683.
40. Brady, H. A., A. Scaria, and W. S. M. Wold. 1992. Map of cis-acting sequences that determine alternative transcription unit of adenovirus. J. Virol. 66:5914.
41. 2 from a macrophage cell line, RAW 264.7. Biochim. Biophys. Acta 963:476.
42. 2) by thrombin and thrombin receptor agonist peptide in human platelets. J. Biol. Chem. 270:14816.
43. 2 by basic fibroblast growth factor via a p42 mitogen-activated protein kinase-dependent phosphorylation pathway in endolhelial cells. J. Biol. Chem. 270:2360.
44. Payne, D. M., A. J. Rossamando, P. Martino, A. K. Erickson, J.-H. Her, J. Shabanowitz, D. F. Hunt, M. J. Weber, and T. W. Sturgill. 1991. Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J. 10:885.
45. Raingeaud, J., S. Gupta, J. Rogers, M. Dickens, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Pro-inflammatory cytokines and environmental stress cause p38 MAP kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270:7420.
46. 2 with membrane in the macrophage cell line RAW 264.7. J. Biol. Chem. 265:5409.
47. Kong, S. K., K. P. Fung, Y. M. Choy, and C. Y. Lee. 1997. Slow increase in intranuclear and cytosolic free calcium concentrations in L929 cells is important in tumour necrosis factor-α-mediated cell death. Oncology 54:55.
48. 2 is coupled to hormonally regulated release of arachidonic acid. Proc. Natl. Acad. Sci. USA 89:6147.
49. 2) in thrombin-stimulated platelets. J. Biol. Chem. 271:27723.
50. 2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J. Biol. Chem. 268:1960.
51. MAPK cascade. J. Biol. Chem. 272:1368.
52. Franklin, C. C., and A. S. Kraft. 1997. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J. Biol. Chem. 272: 16917.
53. Bokemeyer, D., A. Sorokin, M. Yan, N. G. Ahn, D. J. Templeton, and M. J. Dunn. 1996. Induction of mitogen-activated protein kinase phosphatase 1 by the stress-activated protein kinase signaling pathway but not by extracellular signal-regulated kinase in fibroblasts. J. Biol. Chem. 271:639.
54. Sun, H., C. H. Charles, L. F. Lau, and N. K. Tonks. 1993. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75:487.
55. Damay, B. G., and B. B. Aggarwal. 1997. Inhibition of protein tyrosine phosphatases causes phosphorylation of tyrosine-331 in the p60 TNF receptor and inactivates the receptor-associated kinase. FEBS Lett. 410:361.
56. Dhawan, S., S. Singh, and B. B. Aggarwal. 1997. Induction of endothelial cell surface adhesion molecules by TNF is blocked by protein tyrosine phosphatase inhibitors: role of the nuclear transcription factor NF-κB. Eur. J. Immunol. 27: 2172.
57. Wright, S. C., Zheng, H., Zhong, J., Torti, F. M., and J. W. Larrick. 1993. Role of protein phosphorylation in TNF-induced apoptosis: phosphatase inhibitors synergize with TNF to activate DNA fragmentation in normal as well as TNF-resistant U937 variants. J. Cell. Biochem. 53:222.
58. 2 are abrogated by an inhibitor of the p38 mitogen-activated protein kinase cascade in human neutrophils. Biochem. J. 319:17.
59. Cuenda, A., J. Rouse, Y. N. Doza, R. Meier, P. Cohen, T. F. Gallagher, P. R. Young, and J. C. Lee. 1995. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:229.
60. Liu, Z.-G., H. Hsu, D. V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87:565.
61. Natoli, G., A. Costanzo, A. Ianni, D. J. Templeton, J. R. Woodgett, C. Balsano, and M. Levrero. 1997. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 275:200.
62. 2 from a macrophage cell line, RAW 264.7. Biochim. Biophys. Acta 963:476.
63. Voelkel-Johnson, C., A. J. Entingh, W. S. M. Wold, L. R. Gooding, and S. M. Laster. 1995. Activation of intracellular proteases is an early event in TNF-induced apoptosis. J. Immunol. 154:1707.
64. 2 by annexin V in differentiated permeabilized HL-60 cells. J. Biol. Chem. 272:10474.